SCHEMBL22744178

SCHEMBL22744178

C#Cc1cccc(-c2ccc3ncncc3n2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 7/20 0.37
GRM5 P41594 1/20 0.37
CSNK2A1 P68400 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A3 Q8NEV1 1/20 0.35
PIK3CG P48736 1/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
IDO1 P14902 1/20 0.35
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
EGFR P00533 1/20 0.34
ERBB2 P04626 1/20 0.34
ERBB4 Q15303 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29472135 0.78 METAP2 (0.43) MAP4K4NPC1RAB9APIK3CGPIK3CD
SCHEMBL22744476 0.76 MAP4K4 (0.67) MAP4K4MINK1TNIK
SCHEMBL15537120 0.75 KDM4E (0.49) PIK3CGPIK3CDPIK3CAIDO1ALDH1A1
SCHEMBL22744270 0.74 MAP4K4 (0.45) MAP4K4GRM5ALDH1A1CYP1A2CYP3A4
SCHEMBL22744438 0.73 MAP4K4 (0.47) MAP4K4MINK1TNIK
SCHEMBL8274296 0.72 ATM (0.48) GRM5IDO1ABCG2
SCHEMBL22744605 0.71 MAP4K4 (0.45) MAP4K4ALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL4119442 0.71 NPC1 (0.56) MAP4K4NPC1RAB9APIK3CDPIK3CA
SCHEMBL4107230 0.71 KMO (0.47) MAP4K4NPC1RAB9APIK3CGPIK3CD
SCHEMBL737948 0.71 EGFR (0.55) PIK3CDPIK3CAALDH1A1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020239999-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2020-12-03 WO disclosed